Jasper Therapeutics announced the final results of its tender offer to purchase all of its outstanding common stock warrants. The offer, which expired on November 7, 2026, resulted in a significant majority of warrants being tendered for cash.
Key Details
- Tender Results: A total of 8,510,658 warrants were tendered, representing approximately 68.94% of the outstanding warrants.
- Financial Terms: The company will pay $0.324 in cash per warrant, resulting in an aggregate purchase price of approximately $2.76 million ($2,757,453.19).
- Offer Expiration: The offer expired at 12:00 a.m. Eastern Time on November 7, 2026.